Shuxun Yan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shuxun Yan has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Haitao Ma
Department of Peripheral Vascular Medicine, First Affiliated Hospital of Henan University of Traditional Chinese Medicine , Zhengzhou , China
1 shared publicationJixue Wang
Department of Peripheral Vascular Medicine, First Affiliated Hospital of Henan University of Traditional Chinese Medicine , Zhengzhou , China
1 shared publicationTao Zhou
Department of Peripheral Vascular Medicine, First Affiliated Hospital of Henan University of Traditional Chinese Medicine , Zhengzhou , China
1 shared publicationXingxing Yuan
Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine , Harbin , China
1 shared publicationXirui Yang
Department of Ophthalmology, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine , Zhengzhou , China
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 20 (1) , 20251137
Understanding risk factors and prognosis in diabetic foot ulcers
Diabetic foot ulcer (DFU) is a severe and prevalent complication of diabetes mellitus, posing substantial risks to patient health and increasing healthcare burdens globally. These chronic wounds often result from a complex interplay of factors, including neuropathy, ischemia, infection, immune dysregulation, and vascular dysfunction, leading to significant morbidity and, in severe cases, amputation. Effective management of DFUs necessitates a comprehensive understanding of their risk factors and prognostic indicators. This review provides an in-depth examination of the various risk factors and prognostic markers associated with DFUs, integrating insights from cellular mechanisms, emerging biomarkers, omics-based research, serological studies, and clinical assessments. We explore the underlying biological processes, such as the impact of chronic hyperglycemia, oxidative stress, inflammation, impaired angiogenesis, and the role of the microbiome in DFU development. The role of serological markers, including inflammatory and glycemic indicators, in predicting DFU risk and progression is discussed. Additionally, clinical markers and advanced assessment tools, such as ulcer grading systems and imaging technologies, used to evaluate DFU severity and healing are reviewed. By synthesizing these diverse perspectives, this review aims to offer a holistic view of DFU management, highlighting how understanding the interplay of risk factors and prognostic markers can lead to improved prevention strategies and personalized therapeutic interventions.
- 1 January 2025
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 20 (1) , 20251137
Open AccessUnderstanding risk factors and prognosis in diabetic foot ulcers
Diabetic foot ulcer (DFU) is a severe and prevalent complication of diabetes mellitus, posing substantial risks to patient health and increasing healthcare burdens globally. These chronic wounds often result from a complex interplay of factors, including neuropathy, ischemia, infection, immune dysregulation, and vascular dysfunction, leading to significant morbidity and, in severe cases, amputation. Effective management of DFUs necessitates a comprehensive understanding of their risk factors and prognostic indicators. This review provides an in-depth examination of the various risk factors and prognostic markers associated with DFUs, integrating insights from cellular mechanisms, emerging biomarkers, omics-based research, serological studies, and clinical assessments. We explore the underlying biological processes, such as the impact of chronic hyperglycemia, oxidative stress, inflammation, impaired angiogenesis, and the role of the microbiome in DFU development. The role of serological markers, including inflammatory and glycemic indicators, in predicting DFU risk and progression is discussed. Additionally, clinical markers and advanced assessment tools, such as ulcer grading systems and imaging technologies, used to evaluate DFU severity and healing are reviewed. By synthesizing these diverse perspectives, this review aims to offer a holistic view of DFU management, highlighting how understanding the interplay of risk factors and prognostic markers can lead to improved prevention strategies and personalized therapeutic interventions.